216 related articles for article (PubMed ID: 21246740)
1. Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.
Dubois E; Fertin M; Burdese J; Amouyel P; Bauters C; Pinet F
Proteomics Clin Appl; 2011 Feb; 5(1-2):57-66. PubMed ID: 21246740
[TBL] [Abstract][Full Text] [Related]
2. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
3. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
4. Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction.
Fertin M; Beseme O; Duban S; Amouyel P; Bauters C; Pinet F
Proteomics Clin Appl; 2010 Jul; 4(6-7):654-73. PubMed ID: 21137084
[TBL] [Abstract][Full Text] [Related]
5. Plasma proteomics: a noninvasive window on pathology and pediatric cardiac surgery.
Lull ME; Freeman WM; Myers JL; Midgley F; Kimatian SJ; Undar A; Vrana KE
ASAIO J; 2006; 52(5):562-6. PubMed ID: 16966860
[TBL] [Abstract][Full Text] [Related]
6. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
7. High-performance proteomics as a tool in biomarker discovery.
Meyer HE; Stühler K
Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
[TBL] [Abstract][Full Text] [Related]
8. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
9. Application of proteomic technologies to discover and identify biomarkers for excessive alcohol consumption: a review.
Nomura F; Tomonaga T; Sogawa K; Wu D; Ohashi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):35-41. PubMed ID: 17561455
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
[TBL] [Abstract][Full Text] [Related]
12. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
13. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
14. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
15. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
Chen H; Wang D; Bai C; Wang X
J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
[TBL] [Abstract][Full Text] [Related]
17. Proteomic patterns: their potential for disease diagnosis.
Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
Mol Cell Endocrinol; 2005 Jan; 230(1-2):95-106. PubMed ID: 15664456
[TBL] [Abstract][Full Text] [Related]
18. Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
20. Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection.
Ren F; Chen Y; Wang Y; Yan Y; Zhao J; Ding M; Zhang J; Jiang Y; Zhai Y; Duan Z
J Viral Hepat; 2010 Nov; 17(11):816-24. PubMed ID: 20002297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
